Related Experiment Video
Updated: Jan 22, 2026

Stress-induced Antibiotic Susceptibility Testing on a Chip
Published on: January 8, 2014
Different susceptibilities of osteoclasts and osteoblasts to glucocorticoid-induced oxidative stress and
Yu-Hsu Chen1, Shao-Yu Peng2, Ming-Te Cheng3
1Institute of Biotechnology, National Taiwan University, Taipei; Department of Orthopedics, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan; Department of Orthopedics, National Defense Medical Center, Tri-Service General Hospital, Taipei, Taiwan.
Abstract:
Glucocorticoid-induced bone loss is the most common form of secondary osteoporosis. This toxic effect has not been efficiently managed, possibly due to the incomplete understanding of the extraordinarily diverse cellular responses induced by glucocorticoid treatment. Previous literatures revealed that high dose of exogenous glucocorticoid triggers apoptosis in osteocytes and osteoblasts. This cell death is associated with glucocorticoid-induced oxidative stress. In this study, we aimed to investigate the mechanisms of glucocorticoid-induced apoptosis in osteoblasts and examine the responses of osteoclasts to the synthetic glucocorticoid, dexamethasone. We demonstrated the biphasic effects of exogenous glucocorticoid on osteoblastic mitochondrial functions and elevated intracellular oxidative stress in a dose- and time-dependent manner. On comparison, similar treatment did not induce mitochondrial dysfunctions and oxidative stress in osteoclasts. The production of reactive oxygen/nitrogen species was decreased in osteoclasts. The differences are not due to varying efficiency of cellular antioxidant system. The opposite effects on nitrogen oxide synthase might provide an explanation, as the expression levels of nos2 gene are suppressed in the osteoclast but elevated in the osteoblast. We further revealed that glucocorticoids have a substantial impact on the osteoblastic mitochondria. Basal respiration rate and ATP production were increased upon 24 h incubation of glucocorticoids. The increase in proton leak and nonmitochondrial respiration suggests a potential source of glucocorticoid-induced oxidative stress. Long-term incubation of glucocorticoids accumulates these detrimental changes and results in cytochrome C release and mitochondrial breakdown, consequently leading to apoptosis in osteoblasts. The mitochondrial alterations might be other sources of glucocorticoid-induced oxidative stress in osteoblasts.
Insights
Glucocorticoids induce bone loss by causing osteoblast apoptosis via mitochondrial dysfunction and oxidative stress. Osteoclasts are unaffected, highlighting a key difference in cellular response to these drugs.
Area of Science:
- Biochemistry
- Cell Biology
- Endocrinology
Background:
- Glucocorticoid-induced bone loss is a common secondary osteoporosis.
- Current management is limited by incomplete understanding of cellular responses.
- High-dose glucocorticoids induce osteocyte and osteoblast apoptosis, linked to oxidative stress.
Purpose of the Study:
- Investigate mechanisms of glucocorticoid-induced apoptosis in osteoblasts.
- Examine osteoclast responses to dexamethasone.
- Elucidate the role of mitochondrial function and oxidative stress.
Main Methods:
- Dose- and time-dependent analysis of glucocorticoid effects on osteoblasts and osteoclasts.
- Measurement of mitochondrial function (respiration, ATP production).
- Assessment of oxidative stress markers and reactive oxygen/nitrogen species production.
Main Results:
- Glucocorticoids showed biphasic effects on osteoblast mitochondria, increasing oxidative stress.
- Osteoclasts exhibited no mitochondrial dysfunction or increased oxidative stress; reactive oxygen/nitrogen species decreased.
- Elevated nitric oxide synthase 2 (NOS2) in osteoblasts contrasted with suppression in osteoclasts.
- Long-term glucocorticoid exposure led to osteoblast mitochondrial damage, cytochrome C release, and apoptosis.
Conclusions:
- Glucocorticoid-induced bone loss involves osteoblast apoptosis driven by mitochondrial dysfunction and oxidative stress.
- Osteoclasts are resistant to these effects, suggesting differential cellular mechanisms.
- Targeting osteoblast mitochondrial pathways may offer therapeutic strategies for glucocorticoid-induced osteoporosis.
Related Concept Videos
Animal Mitochondrial Genetics
Oxidation Numbers
Osteoclasts in Bone Remodeling
Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...

